Assessment of maintenance therapy with reduced doses of PTH(1-34) in combination with a raloxifene analogue (LY117018) following anabolic therapy in the ovariectomized rat

Bone

Volumn 24, Issue 5, 1999, Pages 451-455

  Hodsman, A B ^a   Watson, P H ^a   Drost, D ^a   Holdsworth, D ^a   Thornton, M ^a   Hock, J ^b   Bryant, H ^b   Fraher, L J ^a  

^a LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Bone mineral density; Ovariectomized rats; Parathyroid hormone; Raloxifene and raloxifene analogues; Selective estrogen receptor modulators

Indexed keywords

6 HYDROXY 2 (4 HYDROXYPHENYL) 3 [4 [2 (1 PYRROLIDINYL)ETHOXY]BENZOYL]BENZO[B]THIOPHENE; ANABOLIC AGENT; PARATHYROID HORMONE[1-34];

AGING; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MASS; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR; LUMBAR SPINE; MAINTENANCE THERAPY; NONHUMAN; ORAL DRUG ADMINISTRATION; OSTEOPENIA; OVARIECTOMY; PELVIS; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TIBIA;

EID: 0032903130     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(99)00015-0     Document Type: Article

References (29)

1. Akhter, M. P., Kimmel, D. B., and Recker, R. R. Effect of parathyroid hormone (hPTH[1-34]) treatment on bone mass and strength in rats. J Bone Miner Res 1994;9:(Suppl 1)S398 (abstract).
2. Baumann B.D., Wronski T.J. Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats. Bone. 16:1995;247-253.
3. 3 or risedronate on endosteal bone remodeling in canine cancellous and cortical bone. J Bone Miner Res. 11:1996;600-613.
4. Bryant H.U., Glasebrook A.L., Yang N.N., Sato K. A pharmacological review of raloxifene. J Bone Miner Metab. 14:1996;1-9.
5. Cheng P.T., Chan C., Muller K. Cyclical treatment of osteopenic ovariectomized adult rats with PTH(1-34) and pamidronate. J Bone Miner Res. 10:1995;119-126.
6. Delmas P.D., Vergnaud P., Arlot M.E., Pastoureau P., Meunier P.J., Nilssen M.H.L. The anabolic effect of human PTH(1-34) on bone formation is blunted when bone resorption is inhibited by bisphosphonate tiludronate - is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodelling system? Bone. 16:1995;603-610.
7. Dempster D.W., Cosman F., Parisien M., Shen V., Lindsay R. Anabolic actions of parathyroid hormone on bone. Endocr Rev. 14:1993;690-709.
8. Evans G.L., Bryant H.U., Magee D.E., Turner R.T. Raloxifene inhibits bone turnover and prevents further cancellous bone loss in adult ovariectomized rats with established osteopenia. Endocrinology. 137:1996;4139-4144.
9. Gunness-Hey M., Hock J.M. Loss of the anabolic effect of parathyroid hormone on bone after discontinuation of hormone in rats. Bone. 10:1989;447-452.
10. Hodsman, A. B., Fraher, L., and Adachi, J. A clinical trial of cyclical clodronate as maintenance therapy following withdrawal of parathyroid hormone, in the treatment of post-menopausal osteoporosis. J Bone Miner Res 1995;10(Suppl 1)S200 (abstract).
11. Hodsman, A. B., Fraher, L. J., and Watson, P. H. Parathyroid hormone: the clinical experience and prospects. In: Whitfield, J. E., Morley, P., Eds. Anabolic treatments for osteoporosis. Boca Raton, FL: CRC; 1998; 83-108.
12. Hodsman A.B., Kiesel M., Fraher L.J., Watson P.H., Stitt L.W. Comparison of the response of pelvic and proximal tibial cancellous bone in rat to ovariectomy with estrogen replacement. Bone. 23:1998;267-274.
13. Kalu D.N. The ovariectomized rat model of postmenopausal bone loss. Bone Miner. 15:1991;175-192.
14. Lindsay, R., Cosman, F., Shen, V., Nieves, J., and Dempster, D. W. Bone mass increments induced by PTH treatment can be maintained by estrogen. J Bone Miner Res 1995;10:S200 (abstract).
15. Lindsay R., Nieves J., Formica C., Henneman E., Woelfert L., Shen V., Dempster D. Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis. Lancet. 350:1997;550-555.
16. Ma Y.F., Jee W.S., Ke H.Z., Lin B.Y., Liang X.G., Li M., Yamamoto N. Human parathyroid hormone-(1-38) restores cancellous bone to the immobilized, osteopenic proximal tibial meaphysis in rats. J Bone Miner Res. 10:1995;496-505.
17. Mitlak B.H., Burdette-Miller P., Schoenfeld D., Neer R.M. Sequential effects of chronic human PTH(1-84) treatment of estrogen-deficiency ostepenia in the rat. J Bone Miner Res. 11:1996;430-439.
18. Qi H., Li M., Wronski T.J. A comparison of the anabolic effects of parathyroid hormone at skeletal sites with moderate and severe osteopenia in aged ovariectomized rats. J Bone Miner Res. 10:1995;948-955.
19. Sato M. Comparative X-ray densitometry of bones from ovariectomized rats. Bone. 17:1995;157S-162S.
20. Sato M., Kim J., Short L.L., Slemenda C., Bryant H.U. Longitudinal and cross-sectional analysis of raloxifene effects on tibiae from ovariectomized aged rats. J Pharmacol Exp Ther. 272:1995;1252-1259.
21. Sato M., McClintock C., Kim J., Turner C.H., Bryant H.U., Magee D.E., Slemenda C.W. Dual-energy x-ray absorptiometry of raloxifene effects on the lumbar vertebrae and femora of ovariectomized rats. J Bone Miner Res. 9:1995;715-724.
22. Sato M., Rippy M.A., Bryant H.U. Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats. FASEB J. 10:1996;905-912.
23. Shen V., Dempster D.W., Birchman R., Xu R., Lindsay R. Loss of cancellous bone mass and connectivity in ovariectomized rats can be restored by combined treatment with parathyroid hormone and estradiol. J Clin Invest. 91:1993;2479-2487.
24. Tada K., Yamanuro T., Okumura H., Kasai R., Takahashi H. Restoration of axial and appendicular bone volumes by hPTH (1-34) in parathyroidectomized and osteopenic rats. Bone. 11:1990;163-169.
25. Talbot J.R., Fischer M.M., Farley S.M., Libanati C., Farley J., Tabuenca A., Baylink D.B. The increase in spinal bone density that occurs in response to fluoride therapy for osteoporosis is not maintained after the therapy is discontinued. Osteoporos Int. 6:1996;442-447.
26. Thompson D.D., Simmons H.A., Pirie C.M., Ke H.Z. FDA guidelines and animal models for osteoporosis. Bone. 17:1995;125S-133S.
27. Wronski T.J., Dann L.M., Scott K.S., Cintrón M. Long-term effects of ovariectomy and aging on the rat skeleton. Calcif Tiss Int. 45:1989;360-366.
28. Wronski T.J., Yen C.-F. The ovariectomized rat as an animal model for postmenopausal bone loss. Cells Mater. 1:(Suppl):1991;69-74.
29. Wronski T.J., Yen C.-F., Dann L.M. Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats. Endocrinology. 132:1993;823-831.